Ikegaki N - Search Results

1

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.

Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10936-41. doi: 10.1073/pnas.190123297. Proc Natl Acad Sci U S A. 2000. PMID: 10984508 Free PMC article.

2

Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.

Tang XX, Brodeur GM, Campling BG, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Clin Cancer Res. 1999 Feb;5(2):455-60. Clin Cancer Res. 1999. PMID: 10037197

3

High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, London W, Cohn SL, Brodeur GM, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Clin Cancer Res. 1999 Jun;5(6):1491-6. Clin Cancer Res. 1999. PMID: 10389937

4

Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.

Eggert A, Ho R, Ikegaki N, Liu XG, Brodeur GM. Eggert A, et al. Among authors: ikegaki n. Med Pediatr Oncol. 2000 Dec;35(6):623-7. doi: 10.1002/1096-911x(20001201)35:6<623::aid-mpo29>3.0.co;2-h. Med Pediatr Oncol. 2000. PMID: 11107132

5

Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.

Tang XX, Zhao H, Robinson ME, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Med Pediatr Oncol. 2000 Dec;35(6):656-8. doi: 10.1002/1096-911x(20001201)35:6<656::aid-mpo37>3.0.co;2-a. Med Pediatr Oncol. 2000. PMID: 11107140

6

Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, Brodeur GM, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Med Pediatr Oncol. 2001 Jan;36(1):80-2. doi: 10.1002/1096-911X(20010101)36:1<80::AID-MPO1019>3.0.CO;2-N. Med Pediatr Oncol. 2001. PMID: 11464911

7

Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.

Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM. Eggert A, et al. Among authors: ikegaki n. Cancer Res. 2002 Mar 15;62(6):1802-8. Cancer Res. 2002. PMID: 11912158

8

Resistance to chemotherapy mediated by TrkB in neuroblastomas.

Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM. Ho R, et al. Among authors: ikegaki n. Cancer Res. 2002 Nov 15;62(22):6462-6. Cancer Res. 2002. PMID: 12438236

9

Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma.

Tang XX, Robinson ME, Riceberg JS, Kim DY, Kung B, Titus TB, Hayashi S, Flake AW, Carpentieri D, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Clin Cancer Res. 2004 Sep 1;10(17):5837-44. doi: 10.1158/1078-0432.CCR-04-0395. Clin Cancer Res. 2004. PMID: 15355914

10

The MYCN enigma: significance of MYCN expression in neuroblastoma.

Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N. Tang XX, et al. Among authors: ikegaki n. Cancer Res. 2006 Mar 1;66(5):2826-33. doi: 10.1158/0008-5472.CAN-05-0854. Cancer Res. 2006. PMID: 16510605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters